Search results
Results from the WOW.Com Content Network
Atomoxetine is sometimes used in the treatment of cognitive impairment and frontal lobe symptoms due to conditions like traumatic brain injury (TBI). [44] [45] It is used to treat ADHD-like symptoms such as sustained attentional problems, disinhibition, [46] lack of arousal, fatigue, and depression, including symptoms from cognitive disengagement syndrome. [44]
Bradycardia; Hypertension (high blood pressure); Allergic reactions (e.g. dyspnoea (shortness of breath), bronchospasm, wheezing, angioneurotic oedema) Anaphylaxis; Changes in appetite
The Panhard 178 from the right side In order to function as an effective long-range reconnaissance vehicle, the Panhard 178 had been kept as light as possible. The vehicle was thus rather small, only 4.79 m (15 ft 9 in) in length, 2.01 m (6 ft 7 in) wide and 2.31 m (7 ft 7 in) in height (1.65 m for the hull per se).
[1] [2] [3] In partnership with Veritas Medicine, it connects site users with appropriate clinical trials. [4] For those seeking general information, MedicineNet (www.medicinenet.com) is an extensive site from Information Network that provides a medical dictionary; databases on pharmaceuticals and their side effects, and diseases and treatments.
A Cochrane review comparing quetiapine to other atypical antipsychotic agents tentatively concluded that it may be less efficacious than olanzapine and risperidone; produce fewer movement related side effects than paliperidone, aripiprazole, ziprasidone, risperidone and olanzapine; and produce weight gain similar to risperidone, clozapine and ...
The usual dosage of etifoxine (as the hydrochloride salt) is 150 to 200 mg per day in divided doses of 50 to 100 mg two to three times per day (e.g., 50 mg–50 mg–100 mg). [ 2 ] [ 7 ] [ 6 ] [ 18 ] [ 1 ] [ 19 ] [ 20 ] It is taken for a few days to a few weeks, but no longer than 12 weeks.
EE/CPA comes in the form of oral tablets and contains 35 or 50 μg EE and 2 mg CPA per tablet. [2] It is taken once daily for 21 days, followed by a 7-day free interval. [ 2 ]
Olanzapine is a potent antagonist of the muscarinic M 3 receptor, [99] which may underlie its diabetogenic side effects. [100] [101] Additionally, it also exhibits a relatively low affinity for serotonin 5-HT 1, GABA A, β-adrenergic receptors, and benzodiazepine binding sites. [43] [102]